Brief: Antisense Therapeutics Announces Appointment Of James Garner As CEO
May 8 (Reuters) - Antisense Therapeutics Ltd ANP.AX :
* APPOINTMENT OF JAMES GARNER AS CHIEF EXECUTIVE OFFICER AND
MANAGING DIRECTOR
* CHARMAINE GITTLESON WILL ASSUME ROLE OF EXECUTIVE CHAIRMAN
Source text for Eikon: ID:nASXwRc1J
Further company coverage: ANP.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Percheron Therapeutics
See all newsBrief: Invion Announces Preclinical Research Collaboration With Percheron Therapeutics
Brief: Percheron Therapeutics Receives Firm Commitments For A$2.3 Million Institutional Placement
Brief: Percheron Therapeutics Appoints Ambrosini as Interim Board Member During CEO Transition Period
Brief: Percheron Therapeutics Says Vanderbilt Health To Conduct Clinical Trial Of Hmbd-002 In Acute Myeloid Leukaemia
Brief: Percheron Therapeutics Says James Garner To Step Down As CEO And Managing Director